Articles with public access mandates - Kenneth E. PalmerLearn more
Not available anywhere: 1
pH-responsive delivery of Griffithsin from electrospun fibers
KM Tyo, J Duan, P Kollipara, MVC dela Cerna, D Lee, KE Palmer, ...
European Journal of Pharmaceutics and biopharmaceutics 138, 64-74, 2019
Mandates: US National Institutes of Health
Available somewhere: 53
Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
BR O'Keefe, B Giomarelli, DL Barnard, SR Shenoy, PKS Chan, ...
Journal of virology 84 (5), 2511-2521, 2010
Mandates: US National Institutes of Health
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
BR O'Keefe, F Vojdani, V Buffa, RJ Shattock, DC Montefiori, J Bakke, ...
Proceedings of the National Academy of Sciences 106 (15), 6099-6104, 2009
Mandates: US National Institutes of Health
Production of pharmaceutical‐grade recombinant aprotinin and a monoclonal antibody product using plant‐based transient expression systems
GP Pogue, F Vojdani, KE Palmer, E Hiatt, S Hume, J Phelps, L Long, ...
Plant biotechnology journal 8 (5), 638-654, 2010
Mandates: US National Institutes of Health
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
N Drayman, JK DeMarco, KA Jones, SA Azizi, HM Froggatt, K Tan, ...
Science 373 (6557), 931-936, 2021
Mandates: US Department of Energy, US National Institutes of Health, Human Frontier …
Griffithsin has antiviral activity against hepatitis C virus
P Meuleman, A Albecka, S Belouzard, K Vercauteren, L Verhoye, ...
Antimicrobial agents and chemotherapy 55 (11), 5159-5167, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Research …
Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12
Y Teng, F Xu, X Zhang, J Mu, M Sayed, X Hu, C Lei, M Sriwastva, ...
Molecular Therapy 29 (8), 2424-2440, 2021
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin
JK Millet, K Séron, RN Labitt, A Danneels, KE Palmer, GR Whittaker, ...
Antiviral research 133, 1-8, 2016
Mandates: US National Institutes of Health
Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate
JC Kouokam, D Huskens, D Schols, A Johannemann, SK Riedell, ...
Plos one 6 (8), e22635, 2011
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models
C Barton, JC Kouokam, AB Lasnik, O Foreman, A Cambon, G Brock, ...
Antimicrobial agents and chemotherapy 58 (1), 120-127, 2014
Mandates: US National Institutes of Health
Griffithsin protects mice from genital herpes by preventing cell-to-cell spread
B Nixon, M Stefanidou, PMM Mesquita, E Fakioglu, T Segarra, L Rohan, ...
Journal of virology 87 (11), 6257-6269, 2013
Mandates: US National Institutes of Health
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
LC Nguyen, D Yang, V Nicolaescu, TJ Best, H Gula, D Saxena, ...
Science Advances 8 (8), eabi6110, 2022
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis
H Yang, J Li, SK Patel, KE Palmer, B Devlin, LC Rohan
Pharmaceutics 11 (4), 184, 2019
Mandates: US National Institutes of Health
Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C
G Ferir, KE Palmer, D Schols
Virology 417 (2), 253-258, 2011
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Technoeconomic modeling of plant-based griffithsin manufacturing
A Alam, L Jiang, GA Kittleson, KD Steadman, S Nandi, JL Fuqua, ...
Frontiers in bioengineering and biotechnology 6, 102, 2018
Mandates: US National Institutes of Health
Display of peptides on the surface of tobacco mosaic virus particles
ML Smith, WP Fitzmaurice, TH Turpen, KE Palmer
Plant-produced microbial vaccines, 13-31, 2009
Mandates: US National Institutes of Health
Griffithsin inhibits Nipah virus entry and fusion and can protect Syrian golden hamsters from lethal Nipah virus challenge
MK Lo, JR Spengler, LRH Krumpe, SR Welch, A Chattopadhyay, ...
The Journal of infectious diseases 221 (Supplement_4), S480-S492, 2020
Mandates: US Department of Energy, US National Institutes of Health
Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in …
KT Hamorsky, TW Grooms-Williams, AS Husk, LJ Bennett, KE Palmer, ...
Antimicrobial agents and chemotherapy 57 (5), 2076-2086, 2013
Mandates: US National Institutes of Health
Bulk production of the antiviral lectin griffithsin
JL Fuqua, K Hamorsky, G Khalsa, N Matoba, KE Palmer
Plant biotechnology journal 13 (8), 1160-1168, 2015
Mandates: US National Institutes of Health
Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV type 1, HIV type 2, and selected carbohydrate-binding agent …
G Férir, D Huskens, KE Palmer, DM Boudreaux, MD Swanson, ...
AIDS research and human retroviruses 28 (11), 1513-1523, 2012
Mandates: US National Institutes of Health, Research Foundation (Flanders)
Publication and funding information is determined automatically by a computer program